Daniel Karp

Companies

• Organon & Co.Executive VP, Corp. Dev. Sep 17, 2024 to now¹
• BiogenEVP, Corporate Development Jun 19, 2018 to Feb 14, 2020²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Organon & Co. OGN69,548 shares³$955.9K at $13.74Mar 31, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 31, 2026Shares withheld for tax 2,105 shares at $5.70 of Organon & Co.³
• Mar 31, 2026Exercised options 6,715 shares of Organon & Co.³
• Mar 31, 2026Shares withheld for tax 3,554 shares at $5.70 of Organon & Co.³
• Mar 31, 2026Exercised options 11,338 shares of Organon & Co.³
• Mar 29, 2026Shares withheld for tax 4,446 shares at $5.84 of Organon & Co.⁴
• Mar 29, 2026Exercised options 14,184 shares of Organon & Co.⁴
• May 6, 2025Bought 3,500 shares at $8.24 of Organon & Co.⁵
• Mar 31, 2025Shares withheld for tax 1,346 shares at $14.51 of Organon & Co.⁶
• Mar 31, 2025Exercised options 4,294 shares of Organon & Co.⁶
• Mar 31, 2025Shares withheld for tax 1,524 shares at $14.51 of Organon & Co.⁶
• Mar 31, 2025Exercised options 4,861 shares of Organon & Co.⁶
• Mar 31, 2025Shares withheld for tax 3,554 shares at $14.51 of Organon & Co.⁶
• Mar 31, 2025Exercised options 11,338 shares of Organon & Co.⁶
• Mar 31, 2025Shares withheld for tax 4,446 shares at $14.51 of Organon & Co.⁶
• Mar 31, 2025Exercised options 14,184 shares of Organon & Co.⁶